MedPath

Ferring Pharmaceuticals, Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.ferringusa.com

A Study of PICOPREP in Patients Needed to Clean the Bowel Prior to X-ray Examination, Endoscopy or Surgery.

Completed
Conditions
Bowel Cleanliness
Interventions
First Posted Date
2011-02-09
Last Posted Date
2012-02-09
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
252
Registration Number
NCT01292109
Locations
🇨🇿

University Hospital, Pilsen, Czech Republic

🇨🇿

Iscare - Prague 7, Prague 7, Czech Republic

Pharmacokinetic (PK) Study of the 200 Microgram (mcg) Misoprostol Vaginal Insert (MVI 200) in Women at Term Gestation (The MVI-PK Study)

Phase 2
Completed
Conditions
Cervical Ripening
Induction of Labor
Interventions
First Posted Date
2011-01-25
Last Posted Date
2014-04-14
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
24
Registration Number
NCT01283022
Locations
🇺🇸

Huntington Memorial Hospital, Pasadena, California, United States

A Study of Tranexamic Acid (XP12B) in Women With Heavy Menstrual Bleeding

Phase 3
Completed
Conditions
Menorrhagia
Interventions
First Posted Date
2011-01-21
Last Posted Date
2011-07-26
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
288
Registration Number
NCT01280981
Locations
🇺🇸

Clinical Trials of Virginia, INC, Richmond, Virginia, United States

🇺🇸

Valley Women's Clinic, Renton, Washington, United States

🇺🇸

North Spokane Women's Center, Spokane, Washington, United States

and more 86 locations

A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).

Phase 3
Completed
Conditions
Central Diabetes Insipidus
Interventions
First Posted Date
2011-01-20
Last Posted Date
2012-08-13
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
20
Registration Number
NCT01280188
Locations
🇯🇵

Aichi Medical University, Nagakute, Aichi, Aichi, Japan

🇯🇵

Nagoya University Hospital, Nagoya, Aichi, Japan

🇯🇵

Saitama Medical Center Jichi Medical University, Saitama, Japan

and more 2 locations

Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients

Phase 3
Completed
Conditions
Nocturia
Interventions
Drug: Placebo
First Posted Date
2010-12-17
Last Posted Date
2015-10-15
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
395
Registration Number
NCT01262456
Locations
🇺🇸

Avail Clinical Research, LLC, DeLand, Florida, United States

🇺🇸

FutureCare Studies, Inc., Springfield, Massachusetts, United States

🇺🇸

Urology Center Research Institute, Englewood, New Jersey, United States

and more 43 locations

A Degarelix Trial in Patients With Prostate Cancer

Phase 3
Terminated
Conditions
Prostate Cancer
Interventions
First Posted Date
2010-11-17
Last Posted Date
2015-06-03
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
288
Registration Number
NCT01242748
Locations
🇺🇸

Urology Associates of Dover, PA, Dover, Delaware, United States

🇨🇿

Vseobecna fakultni nemocnice v Praze, Praha 2, Praha, Czech Republic

🇫🇮

Pohjois-Karjalan keskussairaala, Tampere, Finland

and more 59 locations

A Safety Study in Patients With Advanced Prostate Cancer Treated With FIRMAGON

Completed
Conditions
Prostate Cancer
First Posted Date
2010-11-04
Last Posted Date
2019-06-25
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
1493
Registration Number
NCT01234350
Locations
🇧🇪

Ziekenhuisnetwerk Antwerpen - AZ Stuivenberg, Antwerpen, Belgium

🇧🇪

AZ Sint-Jan AV, Brugge, Belgium

🇧🇪

Université Catholique de Louvain, Bruxelles, Belgium

and more 155 locations

Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)

Phase 4
Completed
Conditions
Infertility
Interventions
First Posted Date
2010-10-21
Last Posted Date
2014-03-14
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
124
Registration Number
NCT01225835
Locations
🇩🇪

IVF Zentrum, Saar, Germany

🇩🇪

Endokrinologikum Ulm, Ulm, Germany

🇩🇪

Fertility Center Berlin, Berlin, Germany

and more 5 locations

Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients

Phase 3
Completed
Conditions
Nocturia
Interventions
Drug: Placebo
First Posted Date
2010-10-19
Last Posted Date
2015-10-15
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
268
Registration Number
NCT01223937
Locations
🇺🇸

Medical Affiliated Research Center Inc., Huntsville, Alabama, United States

🇺🇸

Family Medical Center, Foothill Ranch, California, United States

🇺🇸

Front Range Clinical Research, Wheatridge, Colorado, United States

and more 34 locations

A Study of Minirin Melt in Patients With Nocturia

Completed
Conditions
Nocturia
First Posted Date
2010-10-18
Last Posted Date
2012-10-08
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
588
Registration Number
NCT01222598
Locations
🇨🇿

Trauma Hospital in Brno, Brno, Czech Republic

🇨🇿

Urocentrum, Brno, Czech Republic

🇨🇿

Uromeda, s.r.o., Brno, Czech Republic

and more 25 locations
© Copyright 2025. All Rights Reserved by MedPath